Cancer, unmet need
Cancer remains a major health issue in the world affecting one third of the population
The unmet need
Understanding factors promoting cancer aggressiveness has the potential of finding new targets and treatments helping to cure cancer.
1/3 gets cancer
Cancer remains a major health issue in the world affecting one third of the population
1/5 dies from Cancer
1/5 affected dies from Cancer
+ 62% Projection to 2030
Cancer incidence rates projected increase 2018-2040, worldwide
Ex. Breast Cancer
- Most common cancer in women worldwide
- 2,09 million new cases diagnosed in 2018
- 2nd most common cancer overall
- Represents about 11,6% of all new cancer cases
- 24% of all cancers in women
- Most common cause of death from cancer in women.
(The Global Cancer Observatory, 2018)
Products & Services
Iscaffpharma provides a cost-effective 3D platform to improve success rate in clinical development of treatments for aggressive cancer.
Development support
Target identification
Screening of NCEs on gene expression and other factors
Used technologies
Synthetic scaffolds
Ink/Scaffold available to partners
Patient derived scaffolds
Solid tumours
Restricted number partners
Diagnostics
Precision
Personalized treatment
Liquid biopsy
